HspE7
HspE7
HspE7 (pronounced as H-S-P-E-Seven) is a therapeutic vaccine developed by Stressgen Biotechnologies for the treatment of human papillomavirus (HPV) related diseases.
Etymology
The term HspE7 is an abbreviation for Heat Shock Protein E7. The name is derived from the Heat shock protein (Hsp) family, which are a group of proteins that are produced by cells in response to stressful conditions. The E7 refers to the E7 protein of the HPV virus, which is the target of the vaccine.
Function
HspE7 is designed to stimulate an immune response against cells infected with HPV. It does this by targeting the E7 protein, a viral protein that is produced in all cells infected with HPV. By targeting this protein, the vaccine can help the immune system to recognize and destroy infected cells.
Related Terms
- Therapeutic vaccine: A type of vaccine that is used to treat diseases, rather than prevent them.
- Heat shock protein: A family of proteins that are produced by cells in response to stressful conditions.
- Human papillomavirus: A group of more than 200 related viruses, some of which can lead to cancer.
- E7 protein: A viral protein that is produced in all cells infected with HPV.
External links
- Medical encyclopedia article on HspE7
- Wikipedia's article - HspE7
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski